Delivery Order SPE2DB20D3103-SPE2DB25FN2X3
Award Date
4/3/25
Potential Completion Date
4/4/25
Potential Value
$8.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $12,289.20 for the supply of 1 mg vials of the medication remifentanil. The award has no set-aside designation and an ultimate completion date of October 11, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of REMIFENTANIL 1 MG VIALS. The $2,686.05 firm-fixed-price delivery order has a completion date of December 6, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,448.90 firm fixed-price delivery order is for the supply of 2 mg Remifentanil vials, a specialty medication used for pain management. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,824.58 firm fixed-price delivery order is for the supply of 2 mg vials of the medication Remifentanil. The award is not associated with a set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,239.30 Firm Fixed Price Delivery Order covers the supply of 1 mg vials of the medication Remifentanil. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Remifentanil 1 mg vials, a specialty medication. The fixed-price delivery order has a ceiling value of $3,632.56 and a completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,206.08 firm fixed-price delivery order is for the supply of Remifentanil 1 mg vials, a specialty medication used for pain management. The contract has an ultimate completion date of September 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Remifentanil 2 mg vials. The $1,836.39 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that runs through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award is for the delivery of 2 mg vials of the drug remifentanil, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The $2,909.03 fixed-price delivery order is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,816.30 delivery order is for the supply of REMIFENTANIL 2 MG VIALS, a specialty medication, to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of March 25, 2025. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract...